Bellevue Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-40
| Closed | -$1K | – | 517 |
|
|
2022
Q2 | $1K | Hold |
40
| – | – | ﹤0.01% | 500 |
|
|
2022
Q1 | $1K | Sell |
40
-8
| -17% | -$200 | ﹤0.01% | 536 |
|
|
2021
Q4 | $1K | Sell |
48
-4
| -8% | -$83 | ﹤0.01% | 563 |
|
|
2021
Q3 | $1K | Hold |
52
| – | – | ﹤0.01% | 578 |
|
|
2021
Q2 | $2K | Sell |
52
-5
| -9% | -$192 | ﹤0.01% | 557 |
|
|
2021
Q1 | $2K | Sell |
57
-6
| -10% | -$211 | ﹤0.01% | 618 |
|
|
2020
Q4 | $3K | Buy |
63
+2
| +3% | +$95 | ﹤0.01% | 566 |
|
|
2020
Q3 | $3K | Buy |
61
+20
| +49% | +$984 | ﹤0.01% | 516 |
|
|
2020
Q2 | $3K | Hold |
41
| – | – | ﹤0.01% | 512 |
|
|
2020
Q1 | $3K | Buy |
41
+20
| +95% | +$1.46K | ﹤0.01% | 479 |
|
|
2019
Q4 | $2K | Buy |
+21
| New | +$2K | ﹤0.01% | 473 |
|